CSL USA Inc., a Sacco System company, is expanding its manufacturing facility in Franksville, Wisconsin, with new fully automated encapsulation and bottle packaging capabilities.<\/p>\n\n\n\n
The investment further strengthens CSL USA\u2019s ability to support customers throughout the entire probiotic and postbiotic development journey by bringing even more manufacturing steps together within a single, highly controlled production environment.<\/p>\n\n\n\n
With this expansion, CSL USA\u2019s total U.S. manufacturing footprint will exceed 80,000 square feet.<\/p>\n\n\n\n
The Franksville facility offers an integrated process that includes probiotic fermentation, freeze-drying, blending, encapsulation, and finished product packaging<\/strong>, all within the same manufacturing site.<\/p>\n\n\n\n The new encapsulation and packaging operations take place in a temperature- and humidity-controlled environment maintained at below 20% relative humidity and below 68\u00b0F (20\u00b0C), providing optimal conditions to help preserve probiotic stability and performance throughout the manufacturing process.<\/p>\n\n\n\n For customers, this vertical integration means fewer logistical steps, greater manufacturing efficiency, and a faster, more streamlined path from strain development to a market-ready finished product.<\/p>\n\n\n\n The expansion responds to increasing demand across North America for high-quality, clinically supported probiotic and postbiotic solutions<\/strong>, while also helping customers simplify increasingly complex supply chains. CSL USA combines manufacturing expertise with a broad portfolio of microbial solutions designed to meet a wide range of formulation, positioning, and application needs.<\/p>\n\n\n\n The CultureScience\u2122<\/strong> portfolio includes clinically studied probiotics and postbiotics that can help brands develop differentiated products with targeted health benefits and scientifically supported claims.<\/p>\n\n\n\n The CultureSelect\u2122<\/strong> range, meanwhile, includes more than 70 standard probiotic and postbiotic strains, offering extensive opportunities for customized formulations.<\/p>\n\n\n\n With these expanded manufacturing capabilities, CSL USA can support customers in developing tailored solutions throughout the entire process, from fermenter to finished bottle<\/strong>.<\/p>\n\n\n\n The investment also opens up new opportunities for companies developing Next-Generation Probiotics (NGPs)<\/strong>.<\/p>\n\n\n\n With the expanded facility, CSL USA will be able to support NGP projects not only through strain development and manufacturing, but also as they advance into finished dosage formats.<\/p>\n\n\n\n This capability further strengthens Sacco System\u2019s integrated approach to microbiome innovation, connecting scientific expertise, fermentation technologies, and industrial manufacturing capabilities within a global network.<\/p>\n\n\n\n As a Sacco System company, CSL USA operates within a global organization designed to support customers throughout the entire development lifecycle.<\/p>\n\n\n\n The Group\u2019s expertise spans scientific research, strain development, clinical studies, pilot fermentation, process optimization, formulation, industrial-scale manufacturing, and the production of finished probiotic and postbiotic products<\/strong>.<\/p>\n\n\n\n By integrating these capabilities, Sacco System and CSL USA can support partners in transforming promising microbial technologies into scalable, manufacturable, and commercially viable solutions for markets around the world.<\/p>\n\n\n\n The expansion of the Franksville facility marks another important step in this journey, strengthening Sacco System\u2019s global manufacturing platform and the Group\u2019s ability to turn microbiome innovation into real-world solutions.<\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" CSL USA Inc., a Sacco System company, is expanding its manufacturing facility in Franksville, Wisconsin, with new fully automated encapsulation and bottle packaging capabilities. The investment further strengthens CSL USA\u2019s<\/p>\n","protected":false},"featured_media":38754,"template":"","meta":{"_acf_changed":false},"category_news":[],"tag_news":[],"class_list":["post-38761","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/saccosystem.com\/en\/wp-json\/wp\/v2\/news\/38761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saccosystem.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/saccosystem.com\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saccosystem.com\/en\/wp-json\/wp\/v2\/media\/38754"}],"wp:attachment":[{"href":"https:\/\/saccosystem.com\/en\/wp-json\/wp\/v2\/media?parent=38761"}],"wp:term":[{"taxonomy":"category_news","embeddable":true,"href":"https:\/\/saccosystem.com\/en\/wp-json\/wp\/v2\/category_news?post=38761"},{"taxonomy":"tag_news","embeddable":true,"href":"https:\/\/saccosystem.com\/en\/wp-json\/wp\/v2\/tag_news?post=38761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Meeting growing North American demand for probiotics and postbiotics<\/h2>\n\n\n\n
New opportunities for Next-Generation Probiotics<\/h2>\n\n\n\n
From scientific research to market-ready products<\/h2>\n\n\n\n